TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.050
+0.450 (12.50%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 6:43 PM EST
TriSalus Life Sciences Revenue
TriSalus Life Sciences had revenue of $7.35M in the quarter ending September 30, 2024, with 41.52% growth. This brings the company's revenue in the last twelve months to $26.89M, up 67.90% year-over-year. In the year 2023, TriSalus Life Sciences had annual revenue of $18.51M with 49.31% growth.
Revenue (ttm)
$26.89M
Revenue Growth
+67.90%
P/S Ratio
3.66
Revenue / Employee
$240,098
Employees
112
Market Cap
123.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.51M | 6.11M | 49.31% |
Dec 31, 2022 | 12.40M | 4.00M | 47.58% |
Dec 31, 2021 | 8.40M | 2.97M | 54.60% |
Dec 31, 2020 | 5.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTLSI News
- 5 weeks ago - TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - TriSalus Reports Q3 2024 Financial Results and Provides Business Update - Business Wire
- 5 weeks ago - TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer - Business Wire
- 6 weeks ago - TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment - Business Wire
- 7 weeks ago - TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call - Business Wire
- 2 months ago - TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - Business Wire
- 3 months ago - TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board - Business Wire
- 3 months ago - TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System - Business Wire